News | April 03, 2025
Asahi Kasei Life Science begins operation
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
The acquisition of MDxK further strengthens the Business Unit’s position in the molecular diagnostics market
Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851
Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2206 and BAT2506
The freshly infused capital will primarily be deployed towards expansion and research & development
This program, titled "Food Supplementation and Capacity Building Support for Improved Nutrition in Malinao, Aklan," aligns with the country’s national health
Adults taking Mounjaro with diet and exercise in a controlled clinical trial lost on average 21.8 kg at the highest dose (15mg) and 15.4 kg at the lowest dose (5mg)
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC), will be distributed in the US by Glenmark Therapeutics, USA.
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Subscribe To Our Newsletter & Stay Updated
